|
|
|
(Journal Article): What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?
Ahren B (Department of Medicine, Lund University, Lund, Sweden.,
Bo.Ahren@med.lu.se
)
IN:
Diabetologia
2005; 48(4):605-607
Impact Factor(s) of Diabetologia: 5.583 (2004), 5.689 (2003), 5.136 (2002), 6.299 (2001)
Fulltext:
PDF
ABSTRACT: n.a.
TYPE OF PUBLICATION: Comment
Articles citing this article:
|
Respond
on this Journal Article!
Hint: Your Response should directly apply to What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?.
Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate
subject area. The actual subject area is Dipeptidyl-Peptidase IV Inhibitors.
|
|
|
|
|
